Australian nanomedicine researchers have come up with a new approach to solving a decades-old clinical problem: getting treatment drugs to act selectively on cancer cells in the body. Published this week in the high-impact journal Science Translational Medicine, the research paves the way to safer and more effective treatment options for children with aggressive blood